February 11, 2020

Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment

Category: Article Summary

Topic: Testing and Treatment

• A case series of four 2019-nCoV pneumonia patients admitted to the Shanghai Public Health Clinical Center is presented. Patient recruitment was 21-24 Jan, and data collection occurred through 4 Feb, 2020. 
  • All patients had mild to severe pneumonia with fever. Older patients were hospitalized for longer. Other symptoms, laboratory findings, and treatment regimens are summarized.
  • All four patients were given supplemental oxygen and were treated with allopathic medicine antivirals (combined lopinavir/ritonavir, arbidol); a Chinese traditional medicine, Shufeng Jiedu Capsule (SFJDC); and antibiotics (not specified).
  • The most severe case (63 year old female) was placed on mechanical ventilation and received human seroalbumin and gamma-immunoglobulin.

Wang, et al. (Feb 6, 2020). Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. BioScience Trends. https://doi.org/10.5582/bst.2020.01030